These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11053013)

  • 1. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid.
    Singh PK; Tack BF; McCray PB; Welsh MJ
    Am J Physiol Lung Cell Mol Physiol; 2000 Nov; 279(5):L799-805. PubMed ID: 11053013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme.
    Fernie-King BA; Seilly DJ; Davies A; Lachmann PJ
    Infect Immun; 2002 Sep; 70(9):4908-16. PubMed ID: 12183536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
    Sagel SD; Sontag MK; Accurso FJ
    Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.
    Chen X; Niyonsaba F; Ushio H; Okuda D; Nagaoka I; Ikeda S; Okumura K; Ogawa H
    J Dermatol Sci; 2005 Nov; 40(2):123-32. PubMed ID: 15963694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
    Shugars DC; Watkins CA; Cowen HJ
    Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA.
    van der Linden DS; Short D; Dittmann A; Yu PL
    Biotechnol Lett; 2009 Aug; 31(8):1265-7. PubMed ID: 19396584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of antileukoprotease.
    Hiemstra PS; Maassen RJ; Stolk J; Heinzel-Wieland R; Steffens GJ; Dijkman JH
    Infect Immun; 1996 Nov; 64(11):4520-4. PubMed ID: 8890201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
    Bals R; Wang X; Wu Z; Freeman T; Bafna V; Zasloff M; Wilson JM
    J Clin Invest; 1998 Sep; 102(5):874-80. PubMed ID: 9727055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin That Is Elevated in the Airways during COPD Impairs the Antibacterial Activity of Common Innate Antibiotics.
    Gela A; Bhongir RK; Mori M; Keenan P; Mörgelin M; Erjefält JS; Herwald H; Egesten A; Kasetty G
    PLoS One; 2016; 11(1):e0146192. PubMed ID: 26731746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interactions between mammalian antimicrobial defense peptides.
    Yan H; Hancock RE
    Antimicrob Agents Chemother; 2001 May; 45(5):1558-60. PubMed ID: 11302828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Killing of Pathogenic Escherichia coli Using Camel Lactoferrin from Different Saudi Camel Clans and Various Antibiotics.
    Almehdar HA; El-Baky NA; Alhaider AA; Almuhaideb SA; Alhaider AA; Albiheyri RS; Uversky VN; Redwan EM
    Protein J; 2019 Aug; 38(4):479-496. PubMed ID: 30963371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the antimicrobial effect of lysozyme in combination with antibiotics].
    Bukharin OV; Usviatsov BIa; Zheltova VI; Boldyreva LG
    Antibiotiki; 1978 Nov; 23(11):997-1002. PubMed ID: 363051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option?
    Tomee JF; Koëter GH; Hiemstra PS; Kauffman HF
    Thorax; 1998 Feb; 53(2):114-6. PubMed ID: 9624296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic action of Galleria mellonella apolipophorin III and lysozyme against Gram-negative bacteria.
    Zdybicka-Barabas A; Stączek S; Mak P; Skrzypiec K; Mendyk E; Cytryńska M
    Biochim Biophys Acta; 2013 Jun; 1828(6):1449-56. PubMed ID: 23419829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli.
    Miller KW; Evans RJ; Eisenberg SP; Thompson RC
    J Bacteriol; 1989 Apr; 171(4):2166-72. PubMed ID: 2467900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins.
    van Wetering S; van der Linden AC; van Sterkenburg MA; de Boer WI; Kuijpers AL; Schalkwijk J; Hiemstra PS
    Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L51-8. PubMed ID: 10645890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcal DRS (distantly related to SIC) and SIC inhibit antimicrobial peptides, components of mucosal innate immunity: a comparison of their activities.
    Fernie-King BA; Seilly DJ; Binks MJ; Sriprakash KS; Lachmann PJ
    Microbes Infect; 2007 Mar; 9(3):300-7. PubMed ID: 17303463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect between different milk-derived peptides and proteins.
    López-Expósito I; Pellegrini A; Amigo L; Recio I
    J Dairy Sci; 2008 Jun; 91(6):2184-9. PubMed ID: 18487640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial peptides in the airway.
    Laube DM; Yim S; Ryan LK; Kisich KO; Diamond G
    Curr Top Microbiol Immunol; 2006; 306():153-82. PubMed ID: 16909921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme.
    Leitch EC; Willcox MDP
    J Med Microbiol; 1999 Sep; 48(9):867-871. PubMed ID: 10482299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.